Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel agents for epilepsy and other CNS disorders a focus of investigation at Pfizer

Jan. 18, 2001

Structurally novel series of 5-ht6 receptor antagonists evaluated for SAR

Jan. 18, 2001

In vivo evidence supporting bone marrow as a source of neural cells

Jan. 18, 2001

Adenosine uptake inhibitors useful for cerebral ischemia patented by Bayer

Jan. 17, 2001

Pagoclone enters phase II for treatment of GAD

Jan. 17, 2001

Development of Merck compound for PD discontinued

Jan. 17, 2001

FDA approves Remeron SolTab for treatment of depression

Jan. 17, 2001

Knoll patents compounds useful for depression and other disorders

Jan. 16, 2001

Blockade of E-selectin provides neuroprotection in mouse stroke model

Jan. 15, 2001

Neurogen scientists synthesize new series of brain GABA-A receptor ligands

Jan. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...